logo

For the Inventor, By the Inventor

Pelham, NH, United States of America

David P Reed

This inventor holds 13 USPTO granted patents and 3 EPO patents. Top assignee: Arqule, Inc.. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David P Reed. Retrieved from https://idiyas.com/inventor/david-p-reed-k1tm2no3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 84.6

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 63(Granted Patents)


Location History:

  • Salem, NH (US) (2013 - 2016)
  • Pelham, NH (US) (2016 - 2022)

Company Filing History:

goldMedal13 out of 104 
 
Arqule, Inc.
 patents

Years Active: 2013-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11279679 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine (2022-03-22),
2. 10766868 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine (2020-09-08),
3. 10717710 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2020-07-21),
4. 10227311 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2019-03-12),
5. 10093632 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine (2018-10-09),
6. 9981921 - Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2018-05-29),
7. 9834556 - Process of preparing 3-(3-(4-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-YL)pyridin-2-amine (2017-12-05),
8. 9834519 - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine (2017-12-05),
9. 9499540 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2016-11-22),
10. 9464083 - Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-yl)pyridin-2-amine (2016-10-11),
11. 9422283 - Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound (2016-08-23),
12. 8871933 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2014-10-28),
13. 8552192 - Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same (2013-10-08),

Title: David P Reed: Innovator in Pharmaceutical Chemistry

Introduction

David P Reed is a prominent inventor based in Pelham, NH (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work focuses on innovative methods for preparing complex chemical compounds.

Latest Patents

Among his latest patents, Reed has developed methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine. This application relates to methods of preparing Compound A or a salt thereof, as well as a polymorph of Compound A dihydrochloride salt. These advancements are crucial for the development of new pharmaceutical products.

Career Highlights

Reed is currently associated with Arqule, Inc., where he continues to push the boundaries of chemical research and innovation. His expertise in the field has led to numerous breakthroughs that enhance the efficacy of pharmaceutical compounds.

Collaborations

Throughout his career, Reed has collaborated with notable professionals, including Craig G Bates and Jianmin Mao. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.

Conclusion

David P Reed's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…